Atopic dermatitis exacerbation after Covid‐19 vaccination in Dupilumab‐treated patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atopic dermatitis exacerbation after Covid‐19 vaccination in Dupilumab‐treated patients

Published:2022-02-04 Issue:6 Volume:36 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Potestio L.¹^ORCID,Napolitano M.²^ORCID,Bennardo L.³,Fabbrocini G.¹,Patruno C.³

Affiliation:

1. Section of Dermatology – Department of Clinical Medicine and Surgery University of Naples Federico II Naples Italy

2. Department of Medicine and Health Sciences Vincenzo Tiberio University of Molise Campobasso Italy

3. Department of Health Sciences University Magna Graecia of Catanzaro Catanzaro Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17964

Reference11 articles.

1. Challenges and Issues of Anti-SARS-CoV-2 Vaccines

2. A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development

3. European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics

4. Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis

5. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations;Journal of Asthma and Allergy;2024-08

2. The Past, the Present and the Future of Teledermatology: A Narrative Review;Clinical, Cosmetic and Investigational Dermatology;2024-03

3. Impact of COVID-19 pandemic on adults and children with atopic dermatitis and food allergy: Systematic review;Journal of Allergy and Clinical Immunology: Global;2024-02

4. COVID-19 Does Not Influence the Time to Relapse Following Dupilumab Discontinuation in Patients With Moderate-to-Severe Atopic Dermatitis;DERMATITIS;2023

5. COVID-19 and Its Impact on Common Diseases in the Allergy Clinics;The Journal of Allergy and Clinical Immunology: In Practice;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3